AP2006003628A0 - Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a nonaqueous vehicle - Google Patents

Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a nonaqueous vehicle

Info

Publication number
AP2006003628A0
AP2006003628A0 AP2006003628A AP2006003628A AP2006003628A0 AP 2006003628 A0 AP2006003628 A0 AP 2006003628A0 AP 2006003628 A AP2006003628 A AP 2006003628A AP 2006003628 A AP2006003628 A AP 2006003628A AP 2006003628 A0 AP2006003628 A0 AP 2006003628A0
Authority
AP
ARIPO
Prior art keywords
copolymer
spray formulations
pharmaceutical spray
transdermal pharmaceutical
nonaqueous vehicle
Prior art date
Application number
AP2006003628A
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AP2006003628A0 publication Critical patent/AP2006003628A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2006003628A 2003-10-23 2004-10-21 Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a nonaqueous vehicle AP2006003628A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1122MU2003 2003-10-23
PCT/GB2004/004487 WO2005041943A1 (en) 2003-10-23 2004-10-21 Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle

Publications (1)

Publication Number Publication Date
AP2006003628A0 true AP2006003628A0 (en) 2006-06-30

Family

ID=34531861

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003628A AP2006003628A0 (en) 2003-10-23 2004-10-21 Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a nonaqueous vehicle

Country Status (22)

Country Link
US (1) US20070219171A1 (pt)
EP (1) EP1686969A1 (pt)
JP (1) JP2007509122A (pt)
CN (1) CN100431531C (pt)
AP (1) AP2006003628A0 (pt)
AR (1) AR046146A1 (pt)
AU (1) AU2004285335B2 (pt)
BR (1) BRPI0415725A (pt)
CA (1) CA2543245A1 (pt)
IL (1) IL175094A0 (pt)
MA (1) MA28167A1 (pt)
MX (1) MXPA06004460A (pt)
NO (1) NO20062234L (pt)
NZ (1) NZ547376A (pt)
PA (1) PA8615501A1 (pt)
PE (1) PE20050443A1 (pt)
RU (1) RU2006117527A (pt)
SM (1) SM200400022A (pt)
SV (1) SV2006001916A (pt)
TW (1) TW200524635A (pt)
WO (1) WO2005041943A1 (pt)
ZA (1) ZA200604036B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
CN102018671B (zh) * 2011-01-05 2012-07-25 浙江大学 一种雌二醇透皮喷雾剂及其制备方法
US20150065449A1 (en) * 2011-08-12 2015-03-05 Florida State University Research Foundation, Inc. Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
GB201200062D0 (en) * 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
TWI516281B (zh) * 2014-07-16 2016-01-11 健維生技有限公司 改良之睪固酮製劑製法及所得之睪固酮製劑
JP7145363B2 (ja) * 2015-11-23 2022-10-03 グレイス セラピューティクス インコーポレイテッド 局所皮膜形成スプレー
US11523994B2 (en) 2018-01-10 2022-12-13 Celista Pharmaceuticals Llc Testosterone transdermal spray with film
AU2019299538B2 (en) * 2018-07-05 2025-05-08 Celista Pharmaceuticals Llc Testosterone and estradiol transdermal spray
CN112206222A (zh) * 2018-11-09 2021-01-12 北京德默高科医药技术有限公司 含有布洛芬结构类似物的多层经皮给药系统
CN115154661A (zh) * 2022-07-29 2022-10-11 广州莱度品牌管理有限公司 一种仿生角质膜的制备方法
CN118593475B (zh) * 2024-06-06 2025-07-25 暨南大学 用于治疗帕金森病的组合物、鼻喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625150B2 (en) * 1987-05-27 1992-07-02 Kurt Burghart Transdermal therapeutically effective pharmaceutical dressing and device for applying it
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
FR2739031B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
IT1299566B1 (it) * 1998-07-17 2000-03-16 Ifi Istituto Farmacoterapico I Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
NZ513208A (en) * 1999-02-05 2003-05-30 Cipla Ltd Topical sprays comprising a film forming composition
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US6274167B1 (en) * 2000-09-14 2001-08-14 Vincent Margiotta Topical anesthetic patch
US6528040B1 (en) * 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion

Also Published As

Publication number Publication date
MXPA06004460A (es) 2006-06-27
WO2005041943A1 (en) 2005-05-12
SM200400022B (it) 2005-08-24
PA8615501A1 (es) 2005-10-25
CA2543245A1 (en) 2005-05-12
RU2006117527A (ru) 2007-12-10
KR20070000397A (ko) 2007-01-02
SV2006001916A (es) 2006-03-16
HK1098351A1 (zh) 2007-07-20
AU2004285335A1 (en) 2005-05-12
US20070219171A1 (en) 2007-09-20
CN1897927A (zh) 2007-01-17
SM200400022A (it) 2005-08-24
CN100431531C (zh) 2008-11-12
NZ547376A (en) 2009-07-31
NO20062234L (no) 2006-06-30
BRPI0415725A (pt) 2006-12-19
AU2004285335B2 (en) 2011-02-10
JP2007509122A (ja) 2007-04-12
AR046146A1 (es) 2005-11-23
MA28167A1 (fr) 2006-09-01
IL175094A0 (en) 2006-08-20
PE20050443A1 (es) 2005-06-14
TW200524635A (en) 2005-08-01
EP1686969A1 (en) 2006-08-09
ZA200604036B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
PL378135A1 (pl) 2-Cyjanopirolopirymidyny i ich zastosowania w farmaceutykach
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
IL216931A (en) A pharmacy composition containing Mumtson's Azalastine and Aster
HUP0500456A3 (en) Hepatitis c tripeptide inhibitors, pharmaceutical compositions comprising thereof and their use
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
HUP0300409A3 (en) Pharmaceutical compositions containing antiadhesive carbohydrates and their use
EP1432466A4 (en) MICRONADELBASIS INJECTOR APPARATUS FOR DRUG DELIVERY AND USE METHOD THEREFOR
IL159591A0 (en) Pharmaceutical compositions containing terbinafin and use thereof
AP2006003628A0 (en) Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a nonaqueous vehicle
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
GB0323954D0 (en) Block copolymer and use thereof
AU2003236076A1 (en) Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them
HUP0202223A3 (en) Pseudomycin prodrugs, pharmaceutical compositions comprising thereof and their use
AU2001231964A1 (en) Device for applying active principles for pharmaceutical or cosmetic purposes
EP1683554A4 (en) GAME SOFTWARE AND GAME DEVICE
GB2410187B (en) Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines
IL172096A0 (en) Pharmaceutical formulations comprising amoxicillin and clavulanate
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2003235887A1 (en) Bislactone derivative and use thereof in medicinal composition
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU2003236091A1 (en) Caffeine synthase and use thereof
GB0014849D0 (en) Pharmaceutical aerosol formulation